Fusion Antibodies (LON:FAB) Trading Up 4% – Time to Buy?

Fusion Antibodies plc (LON:FAB)’s share price shot up 4% during mid-day trading on Tuesday . The stock traded as high as GBX 13 and last traded at GBX 13. 1,256 shares were traded during trading, a decline of 100% from the average session volume of 454,344 shares. The stock had previously closed at GBX 12.50.

Fusion Antibodies Stock Up 4.0%

The stock has a 50 day moving average price of GBX 14.04 and a 200 day moving average price of GBX 14.52. The company has a quick ratio of 2.36, a current ratio of 1.80 and a debt-to-equity ratio of 92.42. The stock has a market capitalization of £16.25 million, a price-to-earnings ratio of -8.67 and a beta of 1.22.

Fusion Antibodies Company Profile

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation. These services include antigen expression, antibody production, purification and sequencing, antibody humanisation using Fusion’s proprietary CDRx TM platform and the production of antibody generating stable cell lines to provide material for use in clinical trials.